ABCC7 p.Glu725Lys
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 11950844
[PubMed]
Xie J et al: "A short segment of the R domain of cystic fibrosis transmembrane conductance regulator contains channel stimulatory and inhibitory activities that are separable by sequence modification."
No.
Sentence
Comment
231
One amino acid substitution, noted in a patient with CF, is reported in the CF Mutation Consortium data base in the NEG1 region (E725K).
X
ABCC7 p.Glu725Lys 11950844:231:129
status: NEW
PMID: 12361483
[PubMed]
Chen EY et al: "The PEST sequence does not contribute to the stability of the cystic fibrosis transmembrane conductance regulator."
No.
Sentence
Comment
48
The E725K/E726K mutant was included to test if alteration of charges would affect the function of the PEST sequence.
X
ABCC7 p.Glu725Lys 12361483:48:4
status: NEW51 However, since both S728A and T717A mutant have a high PEST score (T717A mutant alone has PEST score of +3.87), we added an additional E725K mutation to the T717A mutant just to further disrupt the PEST sequence.
X
ABCC7 p.Glu725Lys 12361483:51:135
status: NEW109 Misfolded or misassembled proteins, such as processing defective ∆F508 mutant CFTR, are recognized and retained in the ER by the quality control system in the ER; although the exact mechanism for recognition is yet to be elucidated, evidence indicate that the prolonged association with mo- Table 1: Mutations introduced into the predicted PEST sequence of CFTR Mutant Sequence PEST Score Wild-type (WT) 716 - KTPLQMNGIEEDSDEPLER - 734 +6.91 Poly-Valine 716 - KTPLQMNGIVVVVVVPLER - 734 -26.19 E725K/E726K 716 - KTPLQMNGIKKDSDEPLER - 734 N/A S728A 716 - KTPLQMNGIEEDADEPLER - 734 +4.07 T717A/E725K 716 - KAPLQMNGIKEDSDEPLER - 734 N/A * Residues in bold are the mutations introduced.
X
ABCC7 p.Glu725Lys 12361483:109:500
status: NEWX
ABCC7 p.Glu725Lys 12361483:109:598
status: NEW134 Mature Immature WT CFTR Mature Immature ∆F508 CFTR WT/∆F508 Poly-Valine S728A E725K/E726K T717A/E725K A. B.
X
ABCC7 p.Glu725Lys 12361483:134:92
status: NEWX
ABCC7 p.Glu725Lys 12361483:134:110
status: NEW135 205 130 90 kDa 100 kD 81 kD Immature ∆F508 Poly-Valine ∆F508/Poly-Valine ∆F508/S728A ∆F508/E725K/E726K ∆F508/T717A/E725K volved in protein-protein interactions: direct interaction with ubc9 [33] and ligand recognition [34,35].
X
ABCC7 p.Glu725Lys 12361483:135:119
status: NEWX
ABCC7 p.Glu725Lys 12361483:135:150
status: NEW153 A) Pulse-chase radiograph for non-processing defective constructs: WT, WT/E725K/E726K, and WT/T717A/E725K; results for WT/S728A not shown, but is similar to that of WT.
X
ABCC7 p.Glu725Lys 12361483:153:74
status: NEWX
ABCC7 p.Glu725Lys 12361483:153:100
status: NEW154 B) Pulse-chase radiograph for processing defective constructs: ∆F508, ∆F508/poly-valine, ∆F508/E725K/E726K, and ∆F508/T717/E725K; results for WT/Poly-valine and ∆F508/S728A not shown but they show similar results as ∆F508.
X
ABCC7 p.Glu725Lys 12361483:154:116
status: NEWX
ABCC7 p.Glu725Lys 12361483:154:151
status: NEW156 Hours 0 2 4 6 8 12 24 E725K/E726K Mature Immature T717A/E725KMature Immature WT Mature Immature A.
X
ABCC7 p.Glu725Lys 12361483:156:22
status: NEW157 Hours 0 2 4 6 8 12 24 ∆∆∆∆F508Mature Immature ∆∆∆∆F508/ E725K/E726K Mature Immature ∆∆∆∆F508/ T717A/E725K Mature Immature Mature Immature ∆∆∆∆F508/ Poly-Valine B. mutant protein to not mature suggests otherwise.
X
ABCC7 p.Glu725Lys 12361483:157:112
status: NEWX
ABCC7 p.Glu725Lys 12361483:157:184
status: NEW177 0 0.1 1 10 100 1000 [Trypsin] (µg/ml) T717A/E725KMature Immature E725K/E726KMature Immature S728AMature Immature WTMature Immature Poly-ValineMature Immature ∆F508Mature Immature 0 0.1 1 10 100 1000 [Trypsin] (µg/ml) ∆F508/ Poly-Valine Mature Immature ∆F508/ S728A Mature Immature ∆F508/ E725K/E726K Mature Immature ∆F508/ T717A/E725K Mature Immature the PEST region of another nuclear SUMO-1 target protein, HIPK2 [48].
X
ABCC7 p.Glu725Lys 12361483:177:70
status: NEWX
ABCC7 p.Glu725Lys 12361483:177:326
status: NEWX
ABCC7 p.Glu725Lys 12361483:177:374
status: NEW202 WT/∆F508Mature Immature Poly-ValineMature Immature S728AMature Immature E725K/E726KMature Immature T717A/E725KMature Immature - + - + WT CFTR ∆∆∆∆F508 CFTR 2µµµµM MG-132 tion at 44,000 × g for 45 min. at 4°C and resuspended with 300 µl of TBS (Tris-buffered saline; 10 mM Tris-HCl, pH 7.5, 150 mM NaCl).
X
ABCC7 p.Glu725Lys 12361483:202:79
status: NEW
PMID: 17719933
[PubMed]
Pall H et al: "Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function."
No.
Sentence
Comment
90
Mutations/Variants Polymorphism 1540 locus T Tract Sweat chloride (mmol/L) ⌬Cl ؉ Iso (mV)* PSC 1 GG 7/7 20.2 -1.2 2 GG 7/7 19.7 -17.3 3 R75Q AA 7/7 14.8 -3.9 4 4521G/A(8T/9T) AA 7/7 19.4 -13.3 5 2694T/G AG 7/7 NP NP 6 GG 7/7 5.1 -12.5 7 NP 5.8 -17.8 8 AA 7/7 9.9 -12.8 9 E725K AG 7/7 56.3 -5.1 10 R75Q AA 7/7 30.3 -5.5 11 4006 - 200G/A, 1233A/T AA 7/9 32.1 -29 12 2694T/G AG 7/7 8.7 -2.4 13 4521G/A, 4700T8/9 AG 7/7 4.8 -3.8 14 1525 - 61A/G AG 7/9 45.3 -2.2 15 3030G/A GG 7/7 18.6 -0.45 16 AA 7/7 7.6 -4.5 17 R75Q AG 7/9 21.6 -1.8 18 1001 ϩ 11C/T AG 7/9 45 1.2 19 AA 7/7 11 -11.5 20 1716G ¡ A AG 7/7 18.9 -20.1 IBD 21 1001 ϩ 11C/T AG 7/9 8.9 -13 22 S1235R/2752 - 26A ¡ G 185 ϩ 324C/T AG 7/7 15 -15 23 AG 7/7 17.8 -20 24 IVS8T5 AA 5/7 4.8 -10.4 25 875 ϩ 40A/G, 125G/C GG 7/7 10.8 -30 26 AG 7/7 22.9 -10.5 27 IVS8T5 AG 5/7 15.1 NP 28 AG 7/7 20.1 -8 29 R75Q GG 7/7 10.1 -17 30 AA 7/7 14 NP 31 Q1352H 4521A(hom), 4700T8/8 AG 7/7 3.5 -35 32 AA 7/7 11.8 -8 33 125G/C AG 7/7 9.4 -33 34 R75Q/IVS8T5 1898 ϩ 152T/A AG 5/7 4 -14 Subjects with IBD were disease control subjects.
X
ABCC7 p.Glu725Lys 17719933:90:284
status: NEW91 CFTR mutations shown in bold are E725K, S1235R, and 2752 - 26A ¡ G.
X
ABCC7 p.Glu725Lys 17719933:91:33
status: NEW
PMID: 18306312
[PubMed]
Gene GG et al: "N-terminal CFTR missense variants severely affect the behavior of the CFTR chloride channel."
No.
Sentence
Comment
133
Genotype^Phenotype Correlation in the N-Terminal CFTR MissenseVariants Under Studyà Missense varianta Phenotype Second allele (number of patients)b p.P5L CF p.F508del (1), p.P205S (1) p.S50P CBAVD p.F508del (1), p.E115del (1) p.E60K CF p.G542X (1), p.I507del (1) p.R75Q HT p.F508del (3), p.E725K (1) B p.R347H (1), p.R75Q (1), n.i. (4) Br c.1584G4A (2), c.1210-7_1210-6delTT (1), n.i.(3) NT p.F508del (1) CP c.1584G4A (1), n.i. (3) MI n.i. (1) CUAVD n.i. (2) OZ n.i. (2) Normal p.R75Q (1), c.2052_2053insA (1), n.i. (1) p.G85E CF p.F508del (8), p.G542X (2), p.I507del (1), c.580-1G4T (1), p.G85E (1), c.1477_ 1478delCA (1) CBAVD p.G576A (1) HT p.L997F (1),WT (1) p.G85V CF p.F508del (2), p.G542X (2), p.Y1092X (1), c.265715G4A (1), p.A1006E, c.1210-7_1210- 6delTT (1), n.i. (1) p.Y89C CF n.i. (1)c p.E92K CF p.F508del (2), p.Q890X (1), p.L206W (1) CBAVD c.1210-7_1210-6delTT (1) ÃThe recommendations for mutation nomenclature (www.hgvs.org/mutnomen/) were used to name CFTR gene sequence variations at both the nucleotide level and the protein level.
X
ABCC7 p.Glu725Lys 18306312:133:295
status: NEW
PMID: 16128988
[PubMed]
Larriba S et al: "Molecular evaluation of CFTR sequence variants in male infertility of testicular origin."
No.
Sentence
Comment
53
Thirteen CFTR gene sequence variants [p.R75Q, p.I148T, p.T351S, p.F508del, p.G576A, p.R668C, p.E725K, p.V754M, p.D836Y, p.L997F, p.S1235R, IVS8-6(5T) and c.1716G>A] were determined in 11 F1 and 15 F2 individuals (Table 1) giving a frequency of 29.9%.
X
ABCC7 p.Glu725Lys 16128988:53:95
status: NEW85 Continued No. Phenotype CFTR genotype Associated factors Testicular histologya b c 13 F2 p.I148T p.R75Q No nd 14 F2 p.T351S No nd 15 F2 p.F508del No nd 16 F2 p.E725K No nd 17 F2 p.V754M No nd 18 F2 p.L997F No nd 19 F2 (T)5-(TG)12 No nd 20 F2 (T)5-(TG)12 No nd 21 F2 (T)5-(TG)11 No nd 22 F2 (T)5-(TG)11 No nd 23 F2 c.1716 G>A No nd 24 F2 c.1716 G>A No nd 25 F2 c.1716 G>A No nd 26 F2 c.1716 G>A No nd Phenotype: NOb (SO), non-obstructive severe oligozoospermia; NOb (A), non-obstructive azoospermia; F1, optimal fertility; F2, suboptimal fertility.
X
ABCC7 p.Glu725Lys 16128988:85:160
status: NEW
PMID: 11001817
[PubMed]
Chen JM et al: "Definition of a "functional R domain" of the cystic fibrosis transmembrane conductance regulator."
No.
Sentence
Comment
49
Similarly, E725K and D836Y both occur in well-conserved, FIG. 1.
X
ABCC7 p.Glu725Lys 11001817:49:11
status: NEW